Ireland-based Steris plc, a $3.1b provider of specialty sterilization solutions, equipment processing and endoscope repair services has acquired Key Surgical, a producer of consumables used in minimally-invasive procedures, from private equity firm Water Street. The acquisition adds OR-focused instruments and other sterile, single-use products that builds on Steris’ leading position in infection prevention and reprocessing technologies. Deal terms — $850m …
QIAGEN Acquires NeuMoDx Molecular for $248m
Netherlands-based QIAGEN N.V. (NYSE: QGEN), a $1.5b developer of molecular diagnostic equipment and assays, has acquired a 80.1% ownership stake in diagnostics instruments maker NeuMoDx Molecular, Inc. for $248m. Qiagen had purchased a 19.9% ownership stake in NeuMoDx in 2018. The acquisition builds on QIAGEN’s portfolio of automated molecular testing solutions based on PCR technology. The move also expands QIAGEN’s …
Intersect ENT to Acquire Fiagon AG Medical Technologie
Intersect ENT (Nasdaq: XENT), a $109.1m developer of sinus implants and other ENT-focused products is acquiring Germany-based Fiagon, a developer of proprietary, electromagnetic–based ENT surgical navigation systems for $71.2m. Fiagon’s instruments, produced in Germany, are tip-tracked, enabling surgeons to monitor the full range of instruments deployed during a functional endoscopic sinus surgery procedure, and they also uniquely do not require …
Bruker To Acquire Canopy Biosciences
Bruker Corp. (Nasdaq: BRKR), a $2.1b manufacturer of analytical and diagnostic platforms and instruments is acquiring Canopy Biosciences, a developer of multiplex biomarker imaging technologies for immunology, immuno-oncology and cell therapy to boost Bruker’s CRISPR (clustered regularly interspaced short palindromic repeats) gene editing research capabilities and biopharma drug development business. Canopy Biosciences’ multi-omic (biological analysis) capabilities for immune profiling include …
Royal Philips to Acquire Intact Vascular for $360m
Koninklijke Philips NV (Royal Philips) (NYSE: PHG), a $19.5b Netherlands-based producer of medical technologies and imaging platforms is acquiring Intact Vascular, Inc., a developer of a minimally invasive implantable device to treat Peripheral Artery Disease (PAD), when narrowed blood vessels restrict blood flow to limbs. The acquisition strengthens Philips’ market leading peripheral vascular portfolio which includes advanced interventional imaging systems …
Hologic Acquires Acessa Health for $80M
Hologic (Nasdaq: HOLX), a $3.4b developer of diagnostics, imaging systems, surgical products, and light-based aesthetic and medical treatment platforms for women is buying Acessa Health, the developer of the Acessa ProVu system, a laparoscopic device combining radiofrequency ablation and advanced intra-abdominal ultrasound to treat benign uterine fibroids (tumors). The ProVu procedure, addressing fibroids within the uterine wall and on the …
Thermo Fisher Terminates $12.4b Planned Purchase of Qiagen
After Thermo Fisher originally announced a $11.5b takeover bid for Netherlands-based Qiagen in March, an amended $12.4b acquisition proposal has since lapsed in accordance with its terms, terminating the deal. A campaign against the deal spear-headed by institutional investor Davidson Kempner Capital which owned a 3% stake in Qiagen as of March, lead to a shortfall in reaching the minimum …
Medtronic To Buy Companion Medical
Ireland-based Medtronic plc, a $28.9b maker of cardiac, vascular, diabetes, restorative therapy and minimally invasive devices. is buying Companion Medical, a developer of a “smart” insulin pens and accompanying mobile apps for personalized diabetes management. The deal adds an FDA-cleared, first-of-its kind “smart” insulin device, InPen, to Medtronic’s diabetes offerings. InPen tracks patient insulin dose data, monitors active insulin, recommends …
Teladoc Health to Buy Livongo in $18.5b Mega-Deal
Teladoc (NYSE: TDOC), a $553.3m telemedicine provider, is buying Livongo (Nasdaq: LVGO), a $170.2m digital health and virtual diabetes coaching company, in an $18.5b merger, to create a company with a combined $1.3b in revenue in 2020, up 85% YOY. This is the largest digital health deal in history, ringing in at a purchase price for Livongo at $18.5b, and …
Creo Medical Acquires Albyn Medical for $29.3m
Creo Medical, a UK-based developer of endoscopic microwave and radiofrequency ablation technologies, is acquiring Albyn Medical, a Spain-based manufacturer of branded and third-party gastroenterology, urology and endoscopy products including biopsy forceps, snares, catheters, tubes and valves. The acquisition expands Creo’s GI product suite and provides an entry into Urology. Deal value — $29.3m upfront plus an additional $3.2m in milestones …